Related Experiment Video
Updated: Feb 11, 2026
06:57
Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
Published on: February 12, 2021
3.7K
Overreliance link between asthmatic subjects and short-acting β2 agonists
1Chief Pulmonary Section, Hospital de G Baigorria, Universidad Nacional de Rosario, Argentina.
Pulmonary Pharmacology & Therapeutics
|April 14, 2018
Summary
Young asthma patients can become overly reliant on Short Acting Beta Agonist (SABA) inhalers. This overreliance is linked to near-fatal asthma attacks, highlighting a need for new guideline approaches.
Area of Science:
- Pulmonology
- Asthma Management
- Pharmacology
Background:
- Asthma is a chronic respiratory disease affecting millions globally.
- Short Acting Beta Agonists (SABA) are commonly prescribed for quick relief of asthma symptoms.
- Overreliance on SABA can indicate poor asthma control and increase risks.
Observation:
- This communication highlights a concerning link between young asthmatic individuals and overdependence on SABA.
- The study attempts to define stages of this problematic relationship.
- Prevalence of SABA overreliance is identified as a significant factor in near-fatal asthma exacerbations.
Findings:
- A strong correlation exists between SABA overreliance and severe asthma attacks in young patients.
- The current approach to asthma management may inadvertently foster this dependence.
- This overreliance pattern is a critical factor preceding life-threatening asthma events.
Implications:
- International asthma guidelines require re-evaluation to address SABA overreliance.
- New strategies are necessary to prevent the development of problematic SABA dependence in asthmatics.
- Improved patient education and alternative controller medication strategies are crucial for safer asthma management.
Related Concept Videos
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.9K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.9K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.8K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.8K
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.6K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.6K
01:30Adrenergic Agonists: Direct-Acting Agents
2.9K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
2.9K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.4K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.4K